© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
March 01, 2000
We previously reported that “in vivo purging” with rituximab (Rituxan) during stem-cell collection is safe and does not adversely affect engraftment. We now report on our transplant experience with rituximab. From June 1998 to December